| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 3, 2004
Accepted on January 18, 2005
Montreal Diabetes Research Centre, Centre hospitalier de l'Université de Montréal (CHUM) and the Departments of Medicineand Nutrition, Université de Montréal, Montréal, Québec, Canada
* To whom correspondence should be addressed. E-mail: lise.coderre{at}umontreal.ca.
During metabolic stress, such as ischemia or hypoxia, glucose becomes the principal energy source for the heart. It has been shown that increased cardiac glucose uptake during metabolic stress has a protective effect on cell survival and heart function. Despite its physiological importance, only limited data are available on the molecular mechanisms regulating glucose uptake under these conditions. We used 2,4-dinitrophenol (DNP), an uncoupler of oxidative phosphorylation, as a model to mimic hypoxia and to gain insight into the signaling pathway underlying metabolic stress-induced glucose uptake in primary cultures of rat adult cardiomyocytes. The results demonstrate that 0.1 mM DNP induces 2.2- and 9-fold increases in AMPK and p38 MAPK phosphorylation, respectively. This is associated with a 2.3-fold increase in glucose uptake in these cells. To further delineate the role of AMPK in the regulation of glucose uptake, we used two complementary approaches: pharmacological inhibition of the enzyme with adenine 9-
-D arabinofuranoside (AraA) and adenoviral infection with a dominant-negative AMPK (DN-AMPK) mutant. Our results show that overexpression of DN-AMPK completely suppressed DNP-mediated phosphorylation of acetyl CoA carboxylase, a downstream target of AMPK. Inhibition of AMPK with either AraA or DN-AMPK also abolished DNP-mediated p38 MAPK phosphorylation. Importantly, AMPK inhibition only partially decreased DNP-stimulated glucose uptake in cardiomyocytes. Inhibition of p38 MAPK with the pharmacological agent PD169316 also partially reduced (70%) glucose uptake in response to DNP. In conclusion, our results indicate that p38 MAPK acts downstream of AMPK in cardiomyocytes and that activation of the AMPK/p38 MAPK signaling cascade is essential for maximal stimulation of glucose uptake in response to DNP in adult cardiomyocytes.
This article has been cited by other articles:
![]() |
K. A. Rasbach and R. G. Schnellmann Isoflavones Promote Mitochondrial Biogenesis J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 536 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinmura, K. Tamaki, K. Saito, Y. Nakano, T. Tobe, and R. Bolli Cardioprotective Effects of Short-Term Caloric Restriction Are Mediated by Adiponectin via Activation of AMP-Activated Protein Kinase Circulation, December 11, 2007; 116(24): 2809 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jacquet, E. Zarrinpashneh, A. Chavey, A. Ginion, I. Leclerc, B. Viollet, G. A. Rutter, L. Bertrand, and M. S. Marber The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia Cardiovasc Res, December 1, 2007; 76(3): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Galardo, M. F. Riera, E. H. Pellizzari, S. B. Cigorraga, and S. B. Meroni The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells J. Mol. Endocrinol., October 1, 2007; 39(4): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caretti, S. Morel, G. Milano, M. Fantacci, P. Bianciardi, R. Ronchi, G. Vassalli, L. K. von Segesser, and M. Samaja Heart HIF-1{alpha} and MAP Kinases During Hypoxia: Are They Associated In Vivo? Experimental Biology and Medicine, July 1, 2007; 232(7): 887 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pelletier and L. Coderre Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1325 - E1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1978 - H1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, T. Asano, B. Levine, and J. Sadoshima Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy Circ. Res., March 30, 2007; 100(6): 914 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. LaRosa and S. M. Downs Meiotic Induction by Heat Stress in Mouse Oocytes: Involvement of AMP-Activated Protein Kinase and MAPK Family Members Biol Reprod, March 1, 2007; 76(3): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Rasbach and R. G. Schnellmann Signaling of Mitochondrial Biogenesis following Oxidant Injury J. Biol. Chem., January 26, 2007; 282(4): 2355 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. F. P. Luiken, I. Momken, D. D. J. Habets, M. El Hasnaoui, W. A. Coumans, D. P. Y Koonen, J. F. C. Glatz, and A. Bonen Arsenite Modulates Cardiac Substrate Preference by Translocation of GLUT4, But Not CD36, Independent of Mitogen-Activated Protein Kinase Signaling Endocrinology, November 1, 2006; 147(11): 5205 - 5216. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, N. Jessen, and L. J. Goodyear AMP-activated protein kinase and the regulation of glucose transport Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E867 - E877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Yoon, G. Y. Lee, J.-J. Chung, Y. H. Ahn, S. H. Hong, and J. B. Kim Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator-Activated Receptor {alpha} Diabetes, September 1, 2006; 55(9): 2562 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. LaRosa and S. M. Downs Stress Stimulates AMP-Activated Protein Kinase and Meiotic Resumption in Mouse Oocytes Biol Reprod, March 1, 2006; 74(3): 585 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jing and F. Ismail-Beigi Role of 5'-AMP-activated protein kinase in stimulation of glucose transport in response to inhibition of oxidative phosphorylation Am J Physiol Cell Physiol, February 1, 2006; 290(2): C484 - C491. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Talukdar, W. Szeszel-Fedorowicz, and L. M. Salati Arachidonic Acid Inhibits the Insulin Induction of Glucose-6-phosphate Dehydrogenase via p38 MAP Kinase J. Biol. Chem., December 9, 2005; 280(49): 40660 - 40667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, E. J. Miller, J. Ninomiya-Tsuji, R. R. Russell III, and L. H. Young AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart Circ. Res., October 28, 2005; 97(9): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |